L, K., B, H., R, A., M, J., I, H., C, P., . . . R, A. M. (2018). Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models. Oncology reports, 39(2), 721. https://doi.org/10.3892/or.2017.6137
Chicago Style (17th ed.) CitationL, Karam, Houshaymi B, Abdel-Samad R, Jaafar M, Halloum I, Pisano C, Neipel F, Darwiche N, and Abou Merhi R. "Antitumor Activity of the Synthetic Retinoid ST1926 on Primary Effusion Lymphoma in Vitro and in Vivo Models." Oncology Reports 39, no. 2 (2018): 721. https://doi.org/10.3892/or.2017.6137.
MLA (9th ed.) CitationL, Karam, et al. "Antitumor Activity of the Synthetic Retinoid ST1926 on Primary Effusion Lymphoma in Vitro and in Vivo Models." Oncology Reports, vol. 39, no. 2, 2018, p. 721, https://doi.org/10.3892/or.2017.6137.